Why the study?
Does intravenous nesiritide improve symptoms and oxygenation in a patient with noncardiogenic pulmonary edema resistant to standard therapy?
Population
1 50-year-old African American woman with noncardiogenic pulmonary edema, morbid obesity, acute bronchitis…
Design
Case_report
Follow-up
5 days
Authors
Loading...
May support adjunctive use in refractory noncardiogenic edema; hypothesis-generating and requires randomized confirmation before practice change.
Does intravenous nesiritide improve symptoms and oxygenation in a patient with noncardiogenic pulmonary edema resistant to standard therapy?
Nesiritide may be an effective adjunctive therapy for acute noncardiogenic pulmonary edema resistant to standard-of-care therapies.
Bobadilla et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: